Online citations, reference lists, and bibliographies.

Protein-Nanoparticle Interactions

M. Mizanur Rahman, Sophie Laurent, Nancy Tawil, L'Hocine Yahia, Morteza Mahmoudi
Published 2013 · Chemistry
Cite This
Download PDF
Analyze on Scholarcy
Share
In the recent decade, the fabrication of nanoparticles and exploration of their properties have attracted the attention of all branches of science such as physicists, chemists, biologists, engineers, and even medical doctors. Interests for nanoparticles arise from the fact that their mechanical, chemical, electrical, optical, magnetic, electro-optical, and magneto-optical properties of these nanoparticles are completely different from their bulk properties and the predetermined differences are depended on the physicochemical properties of the nanoparticles. There are numerous areas where nanoparticles are of scientific and technological interest, specifically for medical community, where the synthetic and biologic worlds come together and lead to an important concern for design of safe nano-biomaterials. In this chapter, we review and discuss the major biomedical applications of nanoparticles. 1.1 Nanoscience in Medicine Nanomedicine is the application of nanosciences to health and exploits the physical, chemical, and biological properties of nanomaterials. The advent of nanoscience and nanotechnologies is shaping the face of industrial production and economics. As a matter of fact, nano-based products now include electronic components, paint, sports equipment, fabrics, sunscreens, and other cosmetics [1]. However, the most exciting nano-innovations reside in the conception of new medical products such as heart valves, drug-delivery systems, and imaging techniques [1], which will surely obliterate the long-established boundaries amidst chemistry, physics, and biology. It is anticipated that nanotechnology will have substantial economic impacts by encouraging productivity and competitiveness, converging different disciplines of science and technologies, and stimulating education and human development [2]. Experts predict market growth to hundreds of billions of dollars in the next decade. The worldwide market for products exploiting nanotechnology reached M. Rahman et al., Protein-Nanoparticle Interactions, Springer Series in Biophysics 15, DOI 10.1007/978-3-642-37555-2_1, © Springer-Verlag Berlin Heidelberg 2013 1 about US$254 billion in 2009, with nanomedical products accounting for a margin of US$72.8 billion in 2011 [3]. The US government has granted more than US$20 billion to the US National Nanotechnology Initiative for nanotechnology research and development activities, facilities, and workforce training since 2000 [4]. In 2011, the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA) have granted US $16 million in funding to seven new research projects on regenerative medicine and nanomedicine [5]. The European Framework Program [6] will invest about 600 million euros per year for nanotechnology research until 2013, with a supplementary, comparable sum provided by individual countries [7]. The economic landscape is thus being dramatically altered by nanotechnology. For instance, in 2004, worldwide corporations spent US$3.8 billion on research and development [8]. More importantly, there is a shift from the discovery stage to applications on nanotechnology, as demonstrated by the ratio increased corporate patent applications to scientific publications from 0.23 in 1999 to 1.2 in 2008 [2]. Additionally, analysts estimate that by 2014, nanotechnology will be responsible for 15 % of all manufactured merchandise, valuing approximately US$2.6 trillion and will create 10 million jobs globally [1]. Physicochemical properties of nanoparticles such as their small size, large surface area, and kinetics of adsorption make them particularly interesting as tools for molecular diagnostics, in vivo imaging, and improved treatment of disease. Metal oxides have been introduced in the early 1960s as ferromagnetic separation moieties and have brought about the use of nanoparticles for magnetic resonance imaging (MRI) in the late 1970s. More recently, application of nanoparticles to medicine has expanded to cellular therapy [9], tissue repair [10], drug delivery [11], hyperthermia [12], (MRI) [13], magnetic resonance spectroscopy [14], magnetic separation [15], and as sensors for metabolites and other biomolecule [16]. Moreover, the unique magnetic properties and small size of magnetic nanoparticles (MNPs) make them appealing for biomolecule labeling in bioassays, as well as MRI contrast agents [17]. Superparamagnetic iron oxide (SPIO) can also be used as magnetic gradients for cell sorting in bioreactors [18], as well as absorbing material in radio-frequency hyperthermia. Moreover, the exceptional physical, mechanical, and electronic properties of carbon nanotubes (CNTs) allow them to be used as biosensors, probes, actuators, nanoelectronic devices, drug-delivery systems, and tissue-repair scaffolds within biomedical applications [19–21]. Recent research has focused on conjugating nanocarriers to specific ligands such as peptides, antibodies, and small molecules and subsequently directing them to sites of interest [22]. These techniques can prove to be appealing alternatives for current cancer and cardiovascular applications. Thus, a vast array of nanotechnologies can be applied to medical devices, materials, and processes that will affect the prevention, early diagnosis, and treatment of diseases. However, the risk–benefit balance for these materials, with regard to their toxicological profile and any potential adverse pathogenic reactions from exposure, will ultimately define their clinical outcome. 2 1 The Biological Significance of “Nano”-interactions
This paper references
10.1093/toxsci/kfm217
Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials.
Debamitra Dutta (2007)
10.1038/nrm2652
New roles for endosomes: from vesicular carriers to multi-purpose platforms
Gwyn W. Gould (2009)
10.1021/ja107583h
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.
Marco P. Monopoli (2011)
10.1039/C2RA01374F
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Sophie Laurent (2012)
10.1517/17425247.2011.554818
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
Priya Prakash Karmali (2011)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1016/j.addr.2009.03.009
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
Parag Aggarwal (2009)
10.1038/sj.bjp.0706386
Nanoparticle-induced platelet aggregation and vascular thrombosis.
Anna Radomski (2005)
10.1074/jbc.270.43.25845
β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*)
Arcadio Chonn (1995)
10.1021/cn300205g
Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles.
Mahdi Ghavami (2013)
10.1038/nrc1146
Caveolae: mining little caves for new cancer targets
Lucy A. Carver (2003)
Long-circulating and target-specific nanoparticles: theory to practice.
Seyed Moein Moghimi (2001)
10.1016/j.jconrel.2012.04.009
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
Eugene Mahon (2012)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
Vladimir Torchilin (1995)
10.1021/cr2002596
Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles.
Morteza Mahmoudi (2012)
10.1002/chin.201034225
Testing Metal-Oxide Nanomaterials for Human Safety
Robert Landsiedel (2010)
10.1039/c3cc37307j
Protein corona significantly reduces active targeting yield.
Vahid Mirshafiee (2013)
10.1002/jmri.1880070629
Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.
Anna Moore (1997)
10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
Jayanth Panyam (2003)
10.1016/j.ejpb.2005.02.006
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN).
Torsten M. Göppert (2005)
10.1016/j.biomaterials.2011.08.048
The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles.
Mansooreh Safi (2011)
Cancer cell targeting of lipid gene vectors by protein corona
Giulio Caracciolo (2012)
10.1039/c2nr31185b
Cell "vision": complementary factor of protein corona in nanotoxicology.
Morteza Mahmoudi (2012)
10.1021/cr100440g
Protein-nanoparticle interactions: opportunities and challenges.
Morteza Mahmoudi (2011)
10.1038/nnano.2012.237
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
Anna Salvati (2013)
10.1126/science.1127085
Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
Debdyuti Mukhopadhyay (2007)
10.1038/nchem.1090
Exploring and exploiting chemistry at the cell surface.
Morgan D. Mager (2011)
10.1021/nn2021088
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles.
Morteza Mahmoudi (2011)
10.1080/10611860500071292
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
Torsten M. Göppert (2005)
10.1016/j.biomaterials.2008.09.050
The influence of protein adsorption on nanoparticle association with cultured endothelial cells.
Morton Ehrenberg (2009)
10.1371/journal.pone.0029997
Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision”
Sophie Laurent (2012)
10.1016/0378-5173(87)90034-2
Murine plasma fibronectin depletion after intravenous injection of liposomes
Hans Schreier (1987)
10.1016/j.bbrc.2004.12.137
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse.
Xuedong Yan (2005)
10.1021/am9005463
Complement activation by polymers carrying hydroxyl groups.
Yoshio Arima (2009)
10.1021/nn202458g
The evolution of the protein corona around nanoparticles: a test study.
Martin Lundqvist (2011)
10.1002/jbm.820260403
Albumin-binding surfaces for implantable devices.
Jams R Keogh (1992)
10.1166/jnn.2007.330
Effects of hydrated forms of C60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task.
I Ya Podolski (2007)
10.1038/nnano.2007.223
Immunological properties of engineered nanomaterials.
Marina A Dobrovolskaia (2007)
10.1002/elps.200600694
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.
Hyun Ryoung Kim (2007)
10.1016/j.tox.2005.07.023
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.
János Szebeni (2005)
10.1016/S1387-2656(07)13012-X
Using nanotechnology to improve the characteristics of antineoplastic drugs: improved characteristics of nab-paclitaxel compared with solvent-based paclitaxel.
Maryann Foote (2007)
10.1016/S0005-2736(01)00330-3
Protein adsorption to polyethylene glycol modified liposomes from fibrinogen solution and from plasma.
Mary E. Price (2001)
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.
Sophie Laurent (2011)



This paper is referenced by
10.1111/1751-7915.12021
Sensitivity and specificity of PS/AA-modified nanoparticles used in malaria detection
Raweewan Thiramanas (2013)
10.5075/epfl-thesis-6562
Plasmonic nanostructures for physical and biological applications
Shourya Dutta Gupta (2015)
10.1016/j.heliyon.2020.e04053
Enhanced catalytic activity of Bacillus aryabhattai P1 protease by modulation with nanoactivator
Anupama Prabhakarrao Pathak (2020)
10.1016/j.nano.2017.12.013
Small size fullerenol nanoparticles inhibit thrombosis and blood coagulation through inhibiting activities of thrombin and FXa.
Shibo Xia (2018)
10.1039/c8cc01053f
Interference of citrate-stabilized gold nanoparticles with β2-microglobulin oligomeric association.
Cristina Cantarutti (2018)
10.17077/etd.baout8ym
Spectroscopic studies of silica nanoparticles: magnetic resonance and nanomaterial-biological interactions
Sean E. Lehman (2016)
University of Groningen siRNA-mediated RNA interference in precision-cut tissue slices prepared from mouse lung and kidney Ruigrok,
Mitchel J. R. Maggan (2017)
10.1088/1361-651X/AB3B6E
A multiscale model of protein adsorption on a nanoparticle surface
D. Power (2019)
10.1007/s00216-011-4893-7
Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects
Daniela Drescher (2011)
10.7150/thno.10145
An Array-Based Approach to Determine Different Subtype and Differentiation of Non-Small Cell Lung Cancer
C. C. Li (2015)
10.1016/j.pep.2017.05.007
Recombinant Acetylcholinesterase purification and its interaction with silver nanoparticle.
Fateme Mirzajani (2017)
10.1016/j.actbio.2016.10.023
Effect of anticoagulants on the protein corona-induced reduced drug carrier adhesion efficiency in human blood flow.
Daniel J. Sobczynski (2017)
10.1080/01480545.2018.1424181
In vitro comparative cytotoxicity study of aminated polystyrene, zinc oxide and silver nanoparticles on a cervical cancer cell line
Akash Sharma (2019)
10.1021/jp3046643
Surface chemistry and spectroscopy of human insulin Langmuir monolayer.
Sheba Johnson (2012)
10.1186/1743-8977-11-10
Cytotoxicity and genotoxicity of nano - and microparticulate copper oxide: role of solubility and intracellular bioavailability
Annetta Semisch (2013)
10.3109/17435390.2012.655342
Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses
Zhou J. Deng (2013)
10.1016/J.CEJ.2018.01.011
Interactions between bovine serum albumin and mesoporous silica nanoparticles functionalized with biopolymers
Valentina Nairi (2018)
10.1088/2057-1976/AAC73D
Spectra of secondary particles generated upon virtual irradiation of gold nanosensitizers: implications for surface modification
Alexander Belousov (2018)
10.3390/fib2030187
The Role of the Protein Corona in Fiber Structure-Activity Relationships
Melanie Kucki (2014)
10.7150/thno.4545
Quantum Dots: An Insight and Perspective of Their Biological Interaction and How This Relates to Their Relevance for Clinical Use
Martin J. D. Clift (2012)
10.2147/IJN.S72726
The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles
Zouhir Ekeland Allouni (2015)
10.1016/j.tiv.2018.05.003
Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.
Sherleen Xue-Fu Adamson (2018)
10.1007/s13204-017-0561-3
ZnO nanoparticles (ZnO-NPs) and their antifungal activity against coffee fungus Erythricium salmonicolor
P. A. Arciniegas-Grijalba (2017)
MOLECULAR SIMULATIONS OF ORGANIC-INORGANIC INTERFACE
Sivaprakash Arul (2016)
10.1007/978-3-319-63790-7_18
Gold Nanoparticle Biodistribution and Toxicity: Role of Biological Corona in Relation with Nanoparticle Characteristics
Catherine Carnovale (2017)
University of Birmingham Uptake and impacts of polyvinylpyrrolidone (PVP) capped metal oxide nanoparticles on Daphnia magna
Sophie Marie Briffa (2018)
10.7916/D8N87HVR
Tailoring the (bio)activity of polymeric and metal oxide nano- and microparticles in biotic and abiotic environments
Sathish Ponnurangam (2012)
10.1155/2014/130198
Engineered nanomaterials: knowledge gaps in fate, exposure, toxicity, and future directions
Arun Kumar (2014)
10.3389/fchem.2020.00412
Bimetallic Nanoparticles for Antimicrobial Applications
Naman Arora (2020)
10.3109/17435390.2012.726382
Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model
Agata P. Walczak (2013)
10.1039/c5nr08944a
How should the completeness and quality of curated nanomaterial data be evaluated?
Richard L. Marchese Robinson (2016)
10.1002/9783527800308.CH5
Physicochemical Properties of Engineered Nanomaterials
Linda J. Johnston (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar